233 related articles for article (PubMed ID: 26220995)
1. Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation.
Zheng J; Lang Y; Zhang Q; Cui D; Sun H; Jiang L; Chen Z; Zhang R; Gao Y; Tian W; Wu W; Tang J; Chen Z
Genes Dev; 2015 Jul; 29(14):1524-34. PubMed ID: 26220995
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.
Zhang Q; Xiao H; Chai SC; Hoang QQ; Lu H
J Biol Chem; 2011 Nov; 286(44):38264-38274. PubMed ID: 21903592
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
4. A site-directed mutagenesis study of the MdmX RING domain.
Egorova O; Mis M; Sheng Y
Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
[TBL] [Abstract][Full Text] [Related]
5. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
[TBL] [Abstract][Full Text] [Related]
6. Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.
Wang B; Gao J; Zhao Z; Zhong X; Cui H; Hou H; Zhang Y; Zheng J; Di J; Liu Y
Mol Med; 2022 Sep; 28(1):109. PubMed ID: 36071402
[TBL] [Abstract][Full Text] [Related]
7. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
Linke K; Mace PD; Smith CA; Vaux DL; Silke J; Day CL
Cell Death Differ; 2008 May; 15(5):841-8. PubMed ID: 18219319
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner.
Mahata B; Sundqvist A; Xirodimas DP
Oncogene; 2012 Jun; 31(25):3060-71. PubMed ID: 22081073
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
[TBL] [Abstract][Full Text] [Related]
10. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
Qin L; Yang F; Zhou C; Chen Y; Zhang H; Su Z
J Am Chem Soc; 2014 Dec; 136(52):18023-33. PubMed ID: 25453499
[TBL] [Abstract][Full Text] [Related]
11. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
He X; Li Y; Dai MS; Sun XX
Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
[TBL] [Abstract][Full Text] [Related]
14. Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions.
Lindström MS; Deisenroth C; Zhang Y
Cell Cycle; 2007 Feb; 6(4):434-7. PubMed ID: 17329973
[TBL] [Abstract][Full Text] [Related]
15. Autoinhibition of MDMX by intramolecular p53 mimicry.
Chen L; Borcherds W; Wu S; Becker A; Schonbrunn E; Daughdrill GW; Chen J
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4624-9. PubMed ID: 25825738
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect roles of GRWD1 in the inactivation of p53 in cancer.
Ichikawa MK; Saitoh M
J Biochem; 2022 May; 171(6):601-603. PubMed ID: 35171268
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
[TBL] [Abstract][Full Text] [Related]
18. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
[TBL] [Abstract][Full Text] [Related]
19. MDMX: a novel p53-binding protein with some functional properties of MDM2.
Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
[TBL] [Abstract][Full Text] [Related]
20. HEY1 functions are regulated by its phosphorylation at Ser-68.
López-Mateo I; Arruabarrena-Aristorena A; Artaza-Irigaray C; López JA; Calvo E; Belandia B
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
